Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 165

1.

Effect of Mammography Screening on Mortality by Histological Grade.

Tabar L, Chen TH, Yen AM, Chen SL, Fann JC, Chiu SY, Ku MMS, Wu WY, Hsu CY, Chen YY, Beckmann K, Smith RA, Duffy SW.

Cancer Epidemiol Biomarkers Prev. 2018 Feb;27(2):154-157. doi: 10.1158/1055-9965.EPI-17-0487. Epub 2017 Nov 17.

PMID:
29150482
2.

Initiators and promoters for the occurrence of screen-detected breast cancer and the progression to clinically-detected interval breast cancer.

Yen AM, Wu WY, Tabar L, Duffy SW, Smith RA, Chen HH.

J Epidemiol. 2017 Mar;27(3):98-106. doi: 10.1016/j.je.2016.10.003. Epub 2016 Nov 28.

3.
4.

Evaluation issues in the Swedish Two-County Trial of breast cancer screening: An historical review.

Tabar L, Chen TH, Hsu CY, Wu WY, Yen AM, Chen SL, Chiu SY, Fann JC, Beckmann K, Smith RA, Duffy SW.

J Med Screen. 2017 Mar;24(1):27-33. doi: 10.1177/0969141316631375. Epub 2016 Jun 23.

5.

[Wrong conclusion about overdiagnosis in screening for breast cancer].

Tabár L.

Lakartidningen. 2015 Dec 23;112. pii: DTUS. Swedish. No abstract available.

6.

Systematic review of the breast cancer screening trials is error-ridden.

Tabar L, Day N, Smith R, Chen TH, Yen AM, Duffy S.

J R Soc Med. 2015 Nov;108(11):430-1. doi: 10.1177/0141076815620070. No abstract available.

PMID:
26609097
7.

Socio-medical determinants of timely breastfeeding initiation in Ethiopia: Evidence from the 2011 nation wide Demographic and Health Survey.

Lakew Y, Tabar L, Haile D.

Int Breastfeed J. 2015 Aug 19;10:24. doi: 10.1186/s13006-015-0050-9. eCollection 2015.

8.

Response to Miller et al.

Tabár L, Chen HH, Yen AM, Chen SL, Fann JC, Chiu SY, Smith RA, Duffy SW.

Breast J. 2015 Jul-Aug;21(4):459-61. doi: 10.1111/tbj.12439. Epub 2015 May 25. No abstract available.

PMID:
26010345
9.

Mammographic tumour appearance and triple-negative breast cancer associated with long-term prognosis of breast cancer death: a Swedish Cohort Study.

Tsau HS, Yen AM, Fann JC, Wu WY, Yu CP, Chen SL, Chiu SY, Tabár L, Kuo WH, Chen HH, Chang KJ.

Cancer Epidemiol. 2015 Apr;39(2):200-8. doi: 10.1016/j.canep.2015.01.013. Epub 2015 Feb 26.

PMID:
25731718
10.

Mammography screening study hampered by inadequate data.

Tabár L.

BMJ. 2014 Nov 25;349:g6823. doi: 10.1136/bmj.g6823. No abstract available.

PMID:
25424720
11.

Insights from the breast cancer screening trials: how screening affects the natural history of breast cancer and implications for evaluating service screening programs.

Tabár L, Yen AM, Wu WY, Chen SL, Chiu SY, Fann JC, Ku MM, Smith RA, Duffy SW, Chen TH.

Breast J. 2015 Jan-Feb;21(1):13-20. doi: 10.1111/tbj.12354. Epub 2014 Nov 20.

PMID:
25413699
12.

Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study.

Brem RF, Tabár L, Duffy SW, Inciardi MF, Guingrich JA, Hashimoto BE, Lander MR, Lapidus RL, Peterson MK, Rapelyea JA, Roux S, Schilling KJ, Shah BA, Torrente J, Wynn RT, Miller DP.

Radiology. 2015 Mar;274(3):663-73. doi: 10.1148/radiol.14132832. Epub 2014 Oct 17.

PMID:
25329763
13.

Using tumor phenotype, histological tumor distribution, and mammographic appearance to explain the survival differences between screen-detected and clinically detected breast cancers.

Chuang SL, Chen SL, Yu CP, Chang KJ, Yen AM, Chiu SY, Fann JC, Tabár L, Stephen DW, Smith RA, Chen HH.

APMIS. 2014 Aug;122(8):699-707. doi: 10.1111/apm.12294. Review.

PMID:
25046200
14.

A Proposal to Unify the Classification of Breast and Prostate Cancers Based on the Anatomic Site of Cancer Origin and on Long-term Patient Outcome.

Tabár L, Dean PB, Yen AM, Tarján M, Chiu SY, Chen SL, Fann JC, Chen TH.

Breast Cancer (Auckl). 2014 Feb 25;8:15-38. doi: 10.4137/BCBCR.S13833. eCollection 2014.

15.

Improving the methodology for Listeria monocytogenes detection in smoked salmon by using the wet pooling test.

Vitas AI, Díez-Leturia M, Tabar L, González D.

Int J Food Microbiol. 2014 Aug 1;184:109-12. doi: 10.1016/j.ijfoodmicro.2013.11.036. Epub 2013 Dec 7.

PMID:
24360294
16.

Computer-aided detection of cancer in automated 3-D breast ultrasound.

Tan T, Platel B, Mus R, Tabar L, Mann RM, Karssemeijer N.

IEEE Trans Med Imaging. 2013 Sep;32(9):1698-706. doi: 10.1109/TMI.2013.2263389. Epub 2013 May 16.

PMID:
23693128
17.

Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study.

Holmberg L, Wong YN, Tabár L, Ringberg A, Karlsson P, Arnesson LG, Sandelin K, Anderson H, Garmo H, Emdin S.

Br J Cancer. 2013 Mar 5;108(4):812-9. doi: 10.1038/bjc.2013.26. Epub 2013 Jan 31.

18.

Multifocal breast cancer documented in large-format histology sections: long-term follow-up results by molecular phenotypes.

Pekar G, Hofmeyer S, Tabár L, Tarján M, Chen TH, Yen AM, Chiu SY, Hellberg D, Gere M, Tot T.

Cancer. 2013 Mar 15;119(6):1132-9. doi: 10.1002/cncr.27877. Epub 2012 Dec 27.

19.

The ongoing revolution in breast imaging calls for a similar revolution in breast pathology.

Tabár L, Dean PB, Lindhe N, Ingvarsson M.

Int J Breast Cancer. 2012;2012:489345. doi: 10.1155/2012/489345. Epub 2012 Sep 30.

20.

Breast cancer screening: the evolving evidence.

Smith RA, Duffy SW, Tabár L.

Oncology (Williston Park). 2012 May;26(5):471-5, 479-81, 485-6. Review.

21.

Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening.

Yen AM, Duffy SW, Chen TH, Chen LS, Chiu SY, Fann JC, Wu WY, Su CW, Smith RA, Tabár L.

Cancer. 2012 Dec 1;118(23):5728-32. doi: 10.1002/cncr.27580. Epub 2012 May 17.

22.

Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.

Tarján M, Chen HH, Tot T, Wu W, Lenngren A, Dean PB, Tabár L.

Scand J Urol Nephrol. 2012 Aug;46(4):258-66. doi: 10.3109/00365599.2012.675586. Epub 2012 Apr 23.

PMID:
22519924
23.

The results of a breast cancer screening cAMP at a district level in rural India.

Reddy N, Ninan T, Tabar L, Bevers T.

Asian Pac J Cancer Prev. 2012;13(12):6067-72.

24.

Effect of population-based screening on breast cancer mortality.

Bock K, Borisch B, Cawson J, Damtjernhaug B, de Wolf C, Dean P, den Heeten A, Doyle G, Fox R, Frigerio A, Gilbert F, Hecht G, Heindel W, Heywang-Köbrunner SH, Holland R, Jones F, Lernevall A, Madai S, Mairs A, Muller J, Nisbet P, O'Doherty A, Patnick J, Perry N, Regitz-Jedermann L, Rickard M, Rodrigues V, Del Turco MR, Scharpantgen A, Schwartz W, Seradour B, Skaane P, Tabar L, Tornberg S, Ursin G, Van Limbergen E, Vandenbroucke A, Warren LJ, Warwick L, Yaffe M, Zappa M.

Lancet. 2011 Nov 19;378(9805):1775-6. doi: 10.1016/S0140-6736(11)61766-2. No abstract available. Erratum in: Lancet. 2013 Feb 16;381(9866):536.

PMID:
22098846
25.

Automated 3-D breast ultrasound as a promising adjunctive screening tool for examining dense breast tissue.

Lander MR, Tabár L.

Semin Roentgenol. 2011 Oct;46(4):302-8. doi: 10.1053/j.ro.2011.06.003. Review. No abstract available.

PMID:
22035673
26.

Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.

Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW.

Radiology. 2011 Sep;260(3):658-63. doi: 10.1148/radiol.11110469. Epub 2011 Jun 28.

PMID:
21712474
27.

Breast cancer multifocality, disease extent, and survival.

Tot T, Gere M, Pekár G, Tarján M, Hofmeyer S, Hellberg D, Lindquist D, Chen TH, Yen AM, Chiu SY, Tabár L.

Hum Pathol. 2011 Nov;42(11):1761-9. doi: 10.1016/j.humpath.2011.02.002. Epub 2011 Jun 12.

PMID:
21663941
28.

A new era in the diagnosis and treatment of breast cancer.

Tabár L, Dean PB.

Breast J. 2010 Sep-Oct;16 Suppl 1:S2-4. doi: 10.1111/j.1524-4741.2010.00992.x.

PMID:
21050302
29.

The role of radiological-pathological correlation in diagnosing early breast cancer: the pathologist's perspective.

Tot T, Tabár L.

Virchows Arch. 2011 Feb;458(2):125-31. doi: 10.1007/s00428-010-1005-6. Epub 2010 Nov 3. Review.

PMID:
21046150
30.

Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort.

Hellquist BN, Duffy SW, Abdsaleh S, Björneld L, Bordás P, Tabár L, Viták B, Zackrisson S, Nyström L, Jonsson H.

Cancer. 2011 Feb 15;117(4):714-22. doi: 10.1002/cncr.25650. Epub 2010 Sep 29.

31.

Computer-aided system of evaluation for population-based all-in-one service screening (CASE-PASS): from study design to outcome analysis with bias adjustment.

Chen LS, Yen AM, Duffy SW, Tabar L, Lin WC, Chen HH.

Ann Epidemiol. 2010 Oct;20(10):786-96. doi: 10.1016/j.annepidem.2010.06.003.

PMID:
20816316
32.

Validation of a modelling approach for estimating the likely effectiveness of cancer screening using cancer data on prevalence screening and incidence.

Pashayan N, Pharoah P, Tabár L, Neal DE, Martin RM, Donovan J, Hamdy F, Duffy SW.

Cancer Epidemiol. 2011 Apr;35(2):139-44. doi: 10.1016/j.canep.2010.07.012. Epub 2010 Aug 16.

33.

Effect of baseline breast density on breast cancer incidence, stage, mortality, and screening parameters: 25-year follow-up of a Swedish mammographic screening.

Chiu SY, Duffy S, Yen AM, Tabár L, Smith RA, Chen HH.

Cancer Epidemiol Biomarkers Prev. 2010 May;19(5):1219-28. doi: 10.1158/1055-9965.EPI-09-1028. Epub 2010 Apr 20.

34.

Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England.

Duffy SW, Tabar L, Olsen AH, Vitak B, Allgood PC, Chen TH, Yen AM, Smith RA.

J Med Screen. 2010;17(1):25-30. doi: 10.1258/jms.2009.009094. Erratum in: J Med Screen. 2010 Jun;17(2):106.

35.

Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences.

Holmberg L, Duffy SW, Yen AM, Tabár L, Vitak B, Nyström L, Frisell J.

J Med Screen. 2009;16(2):73-80. doi: 10.1258/jms.2009.008103.

PMID:
19564519
36.

Thirty years of experience with mammography screening: a new approach to the diagnosis and treatment of breast cancer.

Tabar L, Dean PB.

Breast Cancer Res. 2008;10 Suppl 4:S3. doi: 10.1186/bcr2163. Epub 2008 Dec 18. No abstract available.

37.

What information should be given to women invited for mammographic screening for breast cancer?

Duffy SW, Tabar L, Chen TH, Yen AM, Dean PB, Smith RA.

Womens Health (Lond). 2006 Nov;2(6):829-33. doi: 10.2217/17455057.2.6.829.

PMID:
19804001
38.

Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.

Duffy SW, Agbaje O, Tabar L, Vitak B, Bjurstam N, Björneld L, Myles JP, Warwick J.

Breast Cancer Res. 2005;7(6):258-65. Epub 2005 Nov 10.

39.

Tumor size and breast cancer detection: what might be the effect of a less sensitive screening tool than mammography?

Duffy SW, Tabar L, Vitak B, Warwick J.

Breast J. 2006 Jan-Feb;12 Suppl 1:S91-5.

PMID:
16430402
40.

Re: Efficacy of breast cancer screening in the community according to risk level.

Duffy SW, Smith RA, Tabar L.

J Natl Cancer Inst. 2005 Nov 16;97(22):1703; author reply 1703-4. No abstract available.

PMID:
16288125
41.

Screening for breast cancer.

Duffy SW, Smith RA, Gabe R, Tabár L, Yen AM, Chen TH.

Surg Oncol Clin N Am. 2005 Oct;14(4):671-97. Review.

PMID:
16226686
42.

Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma.

Tabar L, Tony Chen HH, Amy Yen MF, Tot T, Tung TH, Chen LS, Chiu YH, Duffy SW, Smith RA.

Cancer. 2004 Oct 15;101(8):1745-59.

43.

The randomized trials of breast cancer screening: what have we learned?

Smith RA, Duffy SW, Gabe R, Tabar L, Yen AM, Chen TH.

Radiol Clin North Am. 2004 Sep;42(5):793-806, v. Review.

PMID:
15337416
44.

Number needed to screen: lives saved over 20 years of follow-up in mammographic screening.

Tabar L, Vitak B, Yen MF, Chen HH, Smith RA, Duffy SW.

J Med Screen. 2004;11(3):126-9.

PMID:
15333270
45.

Clinical assessment of a radiolucent cushion for mammography.

Tabar L, Lebovic GS, Hermann GD, Kaufman CS, Alexander C, Sayre J.

Acta Radiol. 2004 Apr;45(2):154-8.

PMID:
15191098
46.
47.

Mammography and breast cancer: the new era.

Tabár L, Dean PB.

Int J Gynaecol Obstet. 2003 Sep;82(3):319-26. Review.

PMID:
14499978
48.

The relative contributions of screen-detected in situ and invasive breast carcinomas in reducing mortality from the disease.

Duffy SW, Tabar L, Vitak B, Day NE, Smith RA, Chen HH, Yen MF.

Eur J Cancer. 2003 Aug;39(12):1755-60.

PMID:
12888371
49.

Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening.

Yen MF, Tabár L, Vitak B, Smith RA, Chen HH, Duffy SW.

Eur J Cancer. 2003 Aug;39(12):1746-54.

PMID:
12888370
50.

The Swedish Two-County Trial of mammographic screening: cluster randomisation and end point evaluation.

Duffy SW, Tabar L, Vitak B, Yen MF, Warwick J, Smith RA, Chen HH.

Ann Oncol. 2003 Aug;14(8):1196-8.

PMID:
12881376

Supplemental Content

Support Center